Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 01 May 2008
Direct-to-Consumer Advertising (DTCA) has become an accepted reality in the US, where at least three types are regularly used to promote prescription drugs.
"Branded" advertisements promote the drug and its therapeutic effects. "Unbranded" advertisements, a.k.a. "talk to your doctor" advertisements, are used to educate consumers about treatment options that may be available, although the drug remains unnamed. Reminder advertisements simply feature the name of the drug, with no mention of therapeutic claims, diseases or conditions.